Sectoral Asset Management Inc Alkermes Plc. Transaction History

Sectoral Asset Management Inc

$203 Million
Q1 2024

A detailed history of Sectoral Asset Management Inc transactions in Alkermes Plc. stock. As of the latest transaction made, Sectoral Asset Management Inc holds 14,230 shares of ALKS stock, worth $342,943. This represents 0.19% of its overall portfolio holdings.

Number of Shares

14,230

Previous 15,330 7.18%

Holding current value

$342,943

Previous $425,000 9.41%

% of portfolio

0.19%

Previous 0.19%

12 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q1 2024 May 14, 2024	SELL	$26.4 - $32.56 $29,040 - $35,816	-1,100 Reduced 7.18%	14,230 $385,000
Q4 2023 Feb 14, 2024	SELL	$23.37 - $28.68 $5.35 Million - $6.57 Million	-228,930 Reduced 93.72%	15,330 $425,000
Q3 2023 Nov 14, 2023	BUY	$27.17 - $31.97 $56,703 - $66,721	2,087 Added 0.86%	244,260 $6.84 Million
Q2 2023 Aug 11, 2023	BUY	$28.34 - $33.63 $313,808 - $372,384	11,073 Added 4.79%	242,173 $7.58 Million
Q1 2023 May 12, 2023	SELL	$25.31 - $29.02 $20,248 - $23,216	-800 Reduced 0.34%	231,100 $6.51 Million

Q4 2022 Feb 10, 2023	SELL	$21.94 - $26.24 $10,970 - $13,120	-500 Reduced 0.22%	231,900 $6.06 Million
Q3 2022 Nov 10, 2022	BUY	$22.0 - $31.87 $940,500 - $1.36 Million	42,750 Added 22.54%	232,400 $5.19 Million
Q2 2022 Aug 15, 2022	BUY	$26.4 - $30.54 $5.01 Million - $5.79 Million	189,650 New	189,650 $5.65 Million
Q3 2020 Nov 13, 2020	SELL	$16.16 - $20.66 $392,688 - $502,038	-24,300 Closed	0 $0
Q2 2020 Aug 13, 2020	BUY	$13.31 - $19.41 $323,433 - $471,663	24,300 New	24,300 $472,000
Q4 2018 Feb 12, 2019	SELL	$27.94 - $44.61 $575,144 - $918,296	-20,585 Closed	0 $0
Q3 2018 Nov 14, 2018	BUY	$38.6 - $46.12 $794,581 - $949,380	20,585 New	20,585 $874,000

Others Institutions Holding ALKS

# of Institutions

357

Shares Held

180M

Call Options Held

522K

Put Options Held

463K

View Full List

About Alkermes plc.

Ticker ALKS
Exchange NASDAQ
Sector Healthcare
Industry Drug Manufacturers—Specialty & Generic
Shares Outstandng 164,254,000
Market Cap $3.96B
Description
Alkermes plc, a biopharmaceutical company, researches, develops, and commercializes pharmaceutical products to address unmet medical needs of patients in various therapeutic areas in the United States, Ireland, and internationally. Its marketed products include ARISTADA, an intramuscular injectable suspension for the treatment of schizophrenia; ...

More about ALKS

Track This Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of Sectoral Asset Management Inc, based on Form 13F filings with the SEC.

News

Stay updated on Sectoral Asset Management Inc with notifications on news.

Account

Sectoral Asset Management Inc Alkermes Plc. Transaction History